208 related articles for article (PubMed ID: 12742230)
1. Growth inhibitory signalling by TGFbeta is blocked in Ras-transformed intestinal epithelial cells at a post-receptor locus.
Jiang B; Zhang JS; Du J; Urrutia R; Barnard J
Cell Signal; 2003 Jul; 15(7):699-708. PubMed ID: 12742230
[TBL] [Abstract][Full Text] [Related]
2. Ras-mediated suppression of TGFbetaRII expression in intestinal epithelial cells involves Raf-independent signaling.
Bulus NM; Sheng HM; Sizemore N; Oldham SM; Barnett JV; Coffey RJ; Beauchamp DR; Barnard JA
Neoplasia; 2000; 2(4):357-64. PubMed ID: 11005570
[TBL] [Abstract][Full Text] [Related]
3. Resistance to transforming growth factor-beta occurs in the presence of normal Smad activation.
Berger DH; Feng XH; Yao J; Saha D; Beauchamp RD; Lin X
Surgery; 2002 Aug; 132(2):310-6. PubMed ID: 12219028
[TBL] [Abstract][Full Text] [Related]
4. Transformation by oncogenic Ras expands the early genomic response to transforming growth factor beta in intestinal epithelial cells.
Allen CE; Du J; Jiang B; Huang Q; Yakovich AJ; Barnard JA
Neoplasia; 2008 Oct; 10(10):1073-82. PubMed ID: 18813357
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells.
Fujimoto K; Sheng H; Shao J; Beauchamp RD
Exp Cell Res; 2001 Jun; 266(2):239-49. PubMed ID: 11399052
[TBL] [Abstract][Full Text] [Related]
6. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
Du J; Jiang B; Coffey RJ; Barnard J
Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
[TBL] [Abstract][Full Text] [Related]
7. A novel dominant negative Smad2 mutation in a TGFbeta resistant human carcinoma cell line.
Tsang KJ; Tsang D; Brown TN; Crowe DL
Anticancer Res; 2002; 22(1A):13-9. PubMed ID: 12017275
[TBL] [Abstract][Full Text] [Related]
8. A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras.
Kretzschmar M; Doody J; Timokhina I; Massagué J
Genes Dev; 1999 Apr; 13(7):804-16. PubMed ID: 10197981
[TBL] [Abstract][Full Text] [Related]
9. Silencing of the transforming growth factor-beta (TGFbeta) receptor II by Kruppel-like factor 14 underscores the importance of a negative feedback mechanism in TGFbeta signaling.
Truty MJ; Lomberk G; Fernandez-Zapico ME; Urrutia R
J Biol Chem; 2009 Mar; 284(10):6291-300. PubMed ID: 19088080
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of cyclooxygenase-2 in nontransformed and ras-transformed intestinal epithelial cells.
Du J; Jiang B; Barnard J
Neoplasia; 2005 Aug; 7(8):761-70. PubMed ID: 16207478
[TBL] [Abstract][Full Text] [Related]
11. Requirement of Ras/MAPK pathway activation by transforming growth factor beta for transforming growth factor beta 1 production in a Smad-dependent pathway.
Yue J; Mulder KM
J Biol Chem; 2000 Oct; 275(40):30765-73. PubMed ID: 10843986
[TBL] [Abstract][Full Text] [Related]
12. Transformation of intestinal epithelial cells by chronic TGF-beta1 treatment results in downregulation of the type II TGF-beta receptor and induction of cyclooxygenase-2.
Sheng H; Shao J; O'Mahony CA; Lamps L; Albo D; Isakson PC; Berger DH; DuBois RN; Beauchamp RD
Oncogene; 1999 Jan; 18(4):855-67. PubMed ID: 10023661
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic ras represses transforming growth factor-beta /Smad signaling by degrading tumor suppressor Smad4.
Saha D; Datta PK; Beauchamp RD
J Biol Chem; 2001 Aug; 276(31):29531-7. PubMed ID: 11371552
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta down-regulates IL-6 signaling in intestinal epithelial cells: critical role of SMAD-2.
Walia B; Wang L; Merlin D; Sitaraman SV
FASEB J; 2003 Nov; 17(14):2130-2. PubMed ID: 14500551
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological inhibition of Ras-transformed epithelial cell growth is linked to down-regulation of epidermal growth factor-related peptides.
Sizemore N; Cox AD; Barnard JA; Oldham SM; Reynolds ER; Der CJ; Coffey RJ
Gastroenterology; 1999 Sep; 117(3):567-76. PubMed ID: 10464132
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of SMAD2, 4 and 6 mRNA and TGFbeta receptor I mRNA in lesional and non-lesional psoriatic skin.
Yu H; Mrowietz U; Seifert O
Acta Derm Venereol; 2009; 89(4):351-6. PubMed ID: 19688145
[TBL] [Abstract][Full Text] [Related]
17. A raf-independent epidermal growth factor receptor autocrine loop is necessary for Ras transformation of rat intestinal epithelial cells.
Gangarosa LM; Sizemore N; Graves-Deal R; Oldham SM; Der CJ; Coffey RJ
J Biol Chem; 1997 Jul; 272(30):18926-31. PubMed ID: 9228072
[TBL] [Abstract][Full Text] [Related]
18. Regulation of transforming growth factor beta receptors in H-ras oncogene-transformed rat intestinal epithelial cells.
Zhao J; Buick RN
Cancer Res; 1995 Dec; 55(24):6181-8. PubMed ID: 8521411
[TBL] [Abstract][Full Text] [Related]
19. SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor.
Tsukazaki T; Chiang TA; Davison AF; Attisano L; Wrana JL
Cell; 1998 Dec; 95(6):779-91. PubMed ID: 9865696
[TBL] [Abstract][Full Text] [Related]
20. Type II TGF(beta) receptor expression in intestinal cell lines and in the intestinal tract.
Winesett MP; Ramsey GW; Barnard JA
Carcinogenesis; 1996 May; 17(5):989-95. PubMed ID: 8640948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
